In-Hospital Addiction Consultations Put Opioid Users On Path To Recovery

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on April 15, 2025.

By Dennis Thompson HealthDay Reporter

TUESDAY, April 15, 2025 -- People hospitalized for opioid use can better fight their addiction if their path to recovery begins in the hospital, a new study says.

Opioid users who receive addiction consultation services during their hospital stay are significantly more likely to start taking addiction meds and enter a treatment program, researchers reported in JAMA Internal Medicine.

A program to provide addiction consultation “addresses a major challenge across hospitals,” senior researcher Dr. Itai Danovitch, chair of psychiatry and behavioral neurosciences at Cedars-Sinai Medical Center, said in a news release.

“Even though effective medications exist for opioid use disorders, only a small percentage of hospitalized patients begin treatment during their stay or connect with services after discharge,” he said.

More than 81,000 people died from opioid ODs in the U.S. in 2023, researchers said in background notes.

Likewise, hospital admissions for opioid use disorder more than tripled between 2002 and 2018, rising from nearly 302,000 to just under 942,000, researchers said.

For the study, researchers evaluated the effectiveness of a program they called the Substance Use Treatment and Recovery Team (START), in which a doctor paired with a social worker or case manager to help hospitalized patients with opioid addiction.

The team provided patients with prescriptions for addiction medicines like buprenorphine, connections to outside treatment programs, and follow-up telephone calls for a month.

Researchers recruited 325 hospitalized patients 18 or older who likely had opioid use disorder. The patients were admitted between 2021 and 2023 at three U.S. hospitals — Cedars-Sinai in Los Angeles; University of New Mexico Hospital in Albuquerque, N.M.; and Baystate Medical Center in Springfield, Mass.

Half the patients were randomly assigned to the START program, and the other half to usual hospital care.

About 57% of START patients began medication treatment for opioid addiction while in the hospital, compared with just under 27% of patients receiving usual care, results show.

What’s more, 72% of START patients accessed treatment programs and other follow-up care within 30 days after hospital discharge, compared with 48% of the control group, researchers said.

“Hospitalization provides a crucial window to involve patients in addiction treatment when they might be most open to it, particularly after experiencing health-related consequences of their substance use,” Dr. Jeffrey Golden, executive vice dean for research and education at Cedars-Sinai, said in a news release.

“These important findings show how the medical community can significantly boost this engagement and help find solutions for the national opioid epidemic,” added Golden, who was not involved in the study.

Sources

  • Cedars-Sinai Medical Center, news release, April 7, 2024

    • Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

    Source: HealthDay

    Posted : 2025-04-16 00:00

    Read more

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords